The leading global platform for biopharma regulated digital health solutions

00
download icon

Digital health is a significant opportunity for biopharma

Opportunity graphic
00
download icon

BrightInsight can support your high-value regulated digital health use cases

From accelerating clinical development to digital health commercial products that differentiate your therapies – digital is playing a pivotal role in biopharma across therapeutic areas.

Use cases for biopharma patient journey desktop Use cases for biopharma patient journey mobile
arrows graphic

Each one of these use cases requires a trusted and compliant cloud infrastructure.

00
download icon

Key Challenges Exist to Build and Maintain Regulated Digital Health Offerings

Building an in-house digital infrastructure to support your regulated digital health products is a competitive disadvantage for biopharma companies. To drive speed to market and enable your teams to focus on clinical innovation and specific digital health IP that is core to your business, we recommend taking a partner-first approach for your digital health platform.

Hear from top biopharma CIOs about this

00
download icon

BrightInsight takes the hard work out of building, scaling, and maintaining your regulated digital health offerings

BrightInsight replaces the need for lengthy and complex ‘build from scratch’ implementations. Instead, we offer a proven platform and configurable applications, built to meet the most stringent global security, privacy, and regulatory requirements.

Biopharma platform graphic gray circles

When building your digital health solutions on the BrightInsight®️ Platform, you are future-proofing compliance while ensuring scalability across geographies.


00
download icon

Accelerate your time to market while minimizing risk

Our platform reduces the cost of implementation and maintenance, versus a custom solution, and scales across products and global markets.

00
download icon

A trusted partner and proven platform you can count on

Based in Silicon Valley with teams all over the globe, BrightInsight is backed by leading healthcare and technology VCs. Our leadership team brings over 100 years of combined digital health experience in the biopharma and medtech industries.

Our vision is to transform patient outcomes globally by bringing the power of digital technology to healthcare, and we work every day to achieve this by accelerating regulated digital health innovation for our customers through our scalable medical-grade platform.

We are the launch partner and underlying platform for the world’s leading biopharma companies. Our clients trust BrightInsight to accelerate time to market for their regulated digital health products including apps, algorithms, medical devices, connected combination products, companion diagnostics, and Software as a Medical Device.

"We have found in BrightInsight a partner who shares our commitment to advancing public health with innovative, customer-centric solutions. Our engagement with BrightInsight will enable us to bring our digital health solutions to market faster with the goal of improving patient outcomes."

Brian Armstrong, Senior Vice President, Clinical Operations – North America, bioMérieux

Learn More
Bio Merieux logo

"After conducting a rigorous evaluation, we selected BrightInsight because it has the only regulated solution with a robust Quality Management System and a comprehensive list of privacy and security certifications. BrightInsight’s Platform allows us to focus on therapeutic innovation, rather than the underlying digital technology."

Brian Johnson, Director, Digital Health, CSL Behring

Case Study
Customers CSL logo

"Medical-grade digital health platforms like BrightInsight are key to helping us improve the conversation between people with diabetes and their caregivers."

Anders Dyhr Toft, Corporate Vice President, Commercial Innovation, Novo Nordisk

Learn More
Customers Novo logo
00
download icon

Want to learn more?

Visit our Digital Health Resource Center to access our latest white papers, webinars, and more.